EndoRo Endo-navigation Robotic Arm

  • Clinical Condition
    •     Lung cancer is the most common cancer globally, >1.82 million new cases each year and 1.59 million deaths.
    •     If diagnosed in Stage 1, survival rates are 50%, vs. just 1% if diagnosed in Stage 4
    •     Early diagnosis dramatically improves survival but is difficult due to small size of tumor nodules.
  • Current Practice
    •     Large bronchoscopes are introduced in the airways to image and collect tissue samples (biopsy).
    •     Biopsies from lung periphery are obtained blindly with high risk of misdiagnosis.
    •     Bronchoscopes are uncomfortable and patients are exposed to radiation.
    •     Doctors are exposed to radiation and advanced training is difficult.
  • Solution
    •     EndoRoTM uses EM guidance to automatically navigate the biopsy catheter to lung periphery.
    •     Working prototype of EndoRoTM  v1.0 tested on bench model. Provisional patent filed in July 2018.
    •     Medical robotic surgery is predicted to reach $16.74 billion by 2023 at a CAGR of 21%.
    •     Unique solution, existing endovascular robots are manually operated.